[DRESS syndrome associated with levetiracetam use in a pediatric patient. A case report].

Tania Guadalupe Gómez-Moreno, José de Jesús Antonio Ramírez-Hernández, Osvaldo Rafael Ramírez-Ibarra
{"title":"[DRESS syndrome associated with levetiracetam use in a pediatric patient. A case report].","authors":"Tania Guadalupe Gómez-Moreno, José de Jesús Antonio Ramírez-Hernández, Osvaldo Rafael Ramírez-Ibarra","doi":"10.29262/ram.v72i3.1549","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is a drug-related hypersensitivity reaction that manifests with eosinophilia, systemic symptoms, and is sometimes life-threatening. It is clinically characterized by a generalized rash, fever, facial edema, and multiorgan failure. It may be accompanied by paraclinical findings such as leukocytosis, eosinophilia, and abnormalities in renal and liver function tests.</p><p><strong>Case report: </strong>We present the case of a 10-year-old female patient hospitalized with a diagnosis of pansinusitis complicated by epidural empyema requiring surgical drainage. Prior to this, she was treated with levetiracetam. After surgery, she was maintained on a triple regimen of vancomycin, ceftriaxone, and metronidazole. Upon completion of this treatment, she developed a generalized dermatosis that did not respond to second-generation antihistamines or corticosteroids. After this, the patient presented with fever, facial edema, and a seizure. Laboratory studies were ordered, revealing leukocytosis and eosinophilia. DRESS syndrome was suspected, with a RegiSCAR score of 5, corresponding to a probable case. Treatment with immunoglobulin was initiated, with clinical improvement and resolution of the condition observed.</p><p><strong>Conclusions: </strong>DRESS syndrome is a severe drug-induced reaction, with an estimated mortality rate of 10%. Early recognition and timely initiation of treatment are essential for prognosis and prevention of potential complications.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"72 3","pages":"103"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v72i3.1549","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is a drug-related hypersensitivity reaction that manifests with eosinophilia, systemic symptoms, and is sometimes life-threatening. It is clinically characterized by a generalized rash, fever, facial edema, and multiorgan failure. It may be accompanied by paraclinical findings such as leukocytosis, eosinophilia, and abnormalities in renal and liver function tests.

Case report: We present the case of a 10-year-old female patient hospitalized with a diagnosis of pansinusitis complicated by epidural empyema requiring surgical drainage. Prior to this, she was treated with levetiracetam. After surgery, she was maintained on a triple regimen of vancomycin, ceftriaxone, and metronidazole. Upon completion of this treatment, she developed a generalized dermatosis that did not respond to second-generation antihistamines or corticosteroids. After this, the patient presented with fever, facial edema, and a seizure. Laboratory studies were ordered, revealing leukocytosis and eosinophilia. DRESS syndrome was suspected, with a RegiSCAR score of 5, corresponding to a probable case. Treatment with immunoglobulin was initiated, with clinical improvement and resolution of the condition observed.

Conclusions: DRESS syndrome is a severe drug-induced reaction, with an estimated mortality rate of 10%. Early recognition and timely initiation of treatment are essential for prognosis and prevention of potential complications.

[DRESS综合征与小儿左乙拉西坦使用相关][病例报告]。
背景:DRESS综合征(嗜酸性粒细胞增多和全身症状的药物反应)是一种药物相关的超敏反应,表现为嗜酸性粒细胞增多和全身症状,有时会危及生命。临床表现为全身皮疹、发热、面部水肿和多器官功能衰竭。它可能伴随临床表现,如白细胞增多,嗜酸性粒细胞增多,肾功能和肝功能检查异常。病例报告:我们提出的情况下,10岁的女患者住院诊断为全鼻窦炎合并硬膜外脓肿需要手术引流。在此之前,她曾接受左乙拉西坦治疗。术后维持万古霉素、头孢曲松、甲硝唑三联治疗。在完成治疗后,她出现了广泛性皮肤病,对第二代抗组胺药或皮质类固醇没有反应。此后,患者出现发热、面部水肿和癫痫发作。实验室检查显示白细胞增多和嗜酸性粒细胞增多。疑似DRESS综合征,RegiSCAR评分为5分,对应于可能病例。开始使用免疫球蛋白治疗,观察到临床改善和病情缓解。结论:DRESS综合征是一种严重的药物性反应,估计死亡率为10%。早期识别和及时开始治疗对预后和预防潜在并发症至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信